Publication
Cover of publication

Revolutionary power of regenerative medicine

Portrait of Thilo Kaltenbach
Senior Partner
Munich Office, Central Europe
+49 89 9230-8651

Regenerative medicine is a breakthrough treatment option for an increasing number of clinical conditions. It can cure some types of leukemia, significantly improve chronic conditions like cartilage defects or malignant melanomas, and can even be used to construct organ parts, including blood vessels and skin.

Regenerative medicine is on course to transform the pharmaceutical world.
Regenerative medicine is on course to transform the pharmaceutical world.

Nonetheless, this revolution in medicine raises many questions and hurdles. In our study "Regenerative Medicine – The next generation of therapeutic products is set to shake up the pharmaceutical world" we outline how pharmaceutical companies can prepare themselves for the coming transformation.

By strengthening their "innovation radar" and scouting capabilities, reviewing their research and development and commercial models, establishing a supply chain for regenerative medicine, training physicians, as well as developing digital services to support the use of the new products and generate real-life data, Big Pharma can ensure that it will not be left behind.

Study

Regenerative medicine

{[downloads[language].preview]}

The next generation of therapeutic products is set to shake up the pharmaceutical world

vorhanden in
Portrait of Koen Besteman
Principal
Amsterdam Office, Western Europe
+31 20 7960-600
Portrait of Martin Erharter
Senior Partner
Munich Office, Central Europe
+49 89 9230-8414
Portrait of Morris Hosseini
Senior Partner
Berlin Office, Central Europe
+49 160 744-8497
Mehr
  • Photos Chesky_W/iStock; nrqemi/iStock; Yagi-Studio/iStock; Ashley Florence/University of Virginia; A.E. Fletcher Photography / PR.; Jonathan Torgovnik/Getty Images; kovaciclea / iStockphoto; urfinguss / iStockphoto